Answers are grounded in this paper and cite their sources.
The global burden due to microvascular complications in patients with diabetes mellitus persists and even increases alarmingly, the intervention and management are now encountering many difficulties and challenges. This paper reviews the recent advancement and progress in novel biomarkers, artificial intelligence technology, therapeutic agents and approaches of diabetic retinopathy and nephropathy, providing more insights into the management of microvascular complications.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: